PLEASE SEND LOVE AND LIGHT - This clinical trial could impact millions of lives. Yes, ours for sure. I believe in miracles. Much appreciated, One exhausted mama. The University of California at San Diego has been selected to launch the first-ever human test of ViaCyte’s experimental encapsulated cell replacement therapy, called VC-01™ for the treatment of T1D. The JDRF-funded trial is primarily designed to assess the safety of this product candidate so it will begin soon with only a handful of pre-selected people receiving the implant. After evaluating the results from this group, up to 40 people will be enrolled into the study beginning early next year when more trial sites will be added. Additional study details can be found at ClinicalTrials.gov. JDRF has made its encapsulation research program a priority because of its potential to transform the way individuals with T1D manage their disease. If successful, cell replacement products like the one JDRF is supporting at ViaCyte could free people with T1D from daily insulin injections or external pumps.
Posted on: Tue, 16 Sep 2014 17:39:45 +0000
Trending Topics
Recently Viewed Topics
© 2015